Serum follicle-stimulating hormone levels predict time to development of castration-resistant prostate cancer

INTRODUCTION: Treatment of advancing prostate cancer focuses on blocking the activation of the androgen receptor with resultant prolonged perturbation of the hypothalamic-pituitary-gonadal axis. Androgen deprivation therapy (ADT) is marked, however, by eventual progression to castration- resistant p...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Can Urol Assoc J
Asıl Yazarlar: Hoare, Dylan, Skinner, Thomas A.A., Black, Angela, Robert Siemens, D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Canadian Medical Association 2015
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4455620/
https://ncbi.nlm.nih.gov/pubmed/26085869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.2545
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller